Reviews in Endocrine & Metabolic Disorders

Papers
(The median citation count of Reviews in Endocrine & Metabolic Disorders is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review182
Traumatic brain injury and prolactin174
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health162
Pegvisomant in managing comorbidities of acromegaly: a review145
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus141
Association between metabolic dysfunction-associated steatotic liver disease/non-alcoholic fatty liver disease and chronic kidney disease: a systematic review and meta-analysis131
Diagnostic and prognostic utility of phase angle in patients with cancer97
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus83
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb81
Can breastfeeding practices explain sociodemographic disparities in childhood obesity and healthy eating? Results from NHANES 2005–201878
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review73
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review67
The genetics of Graves’ disease62
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review60
Looking beyond fat in obesity: the frequently overlooked importance of muscle mass59
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?57
Preface56
Endocrine responses of the stress system to different types of exercise56
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality56
Prolactin deficiency in the context of other pituitary hormone abnormalities55
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease54
Use of thermal imaging in the detection of the diabetic foot- review49
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond48
Emerging role of AgRP neurons as integrators of metabolic, sensory and environmental cues in the control of energy homeostasis46
Mention to Prof. Andrew V. Schally46
Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatiti46
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease46
Exercise remodels the skeletal muscle immune microenvironment to ameliorate type 2 diabetes mellitus-induced muscle atrophy: From immunometabolism to organ crosstalk45
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries42
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy41
Hypothalamic GHRH41
Neurovascular plasticity as a modulator of hypothalamic function40
Efficacy of different types of intermittent fasting in improving glycemic control in adults with overweight or obesity: a systematic review and network meta-analysis40
Virtual reality interventions in obesity and eating disorders: a systematic review of biomarker, clinical, and behavioral outcomes39
No longer to be ignored: Hypophosphatemia following intravenous iron administration38
The hypothalamus as a therapeutic target: Towards novel approaches for managing antipsychotic-induced weight gain38
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis37
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence37
Deep neural network for food image classification and nutrient identification: A systematic review36
Correction: Hypothalamic GHRH35
Towards precision medicine in non-alcoholic fatty liver disease35
Interaction of physical activity and gut-brain axis: relevance for obesity35
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome35
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis34
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities32
Bridging the gap: recommendations to accomplish transition from pediatric to adult care in adolescents living with obesity31
LEAP2 as a therapeutic target in obesity and cardiometabolic disorders31
Uterine fibroids in women diagnosed with acromegaly: a systematic review30
Regulation of adipogenesis by exosomal milk miRNA30
Rathke’s cleft cyst: From history to molecular genetics29
Effect of acute postprandial exercise on continuous glucose monitoring outcomes in type 2 diabetes: A systematic review and meta-analysis of crossover trials28
GHRH in diabetes and metabolism28
Mammary adipocyte plasticity and epithelial crosstalk: roles in development, remodeling, and disease28
Diabetes and cancer: glucose control impact on survival and tumor outcomes28
Molecular testing for thyroid nodules: Where are we now?27
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences27
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients27
Hypoprolactinemia, a neglected endocrine disorder26
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury25
Phase angle in applications of bioimpedance in health and disease25
Role of thyroid peroxidase in health and disease: A comprehensive update on TPO gene and protein expression, enzymatic activity and pharmacological modulation25
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity25
Prolactin: structure, receptors, and functions25
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review25
Correction: Early-life programming of hypothalamic circuits by maternal obesity: implications for neuroendocrine disorders24
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease24
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions24
Reference intervals for serum prolactin concentrations: analytical and clinical considerations23
BBSome: An essential component of hypothalamic regulation of energy homeostasis23
Phase angle and COVID-19: A systematic review with meta-analysis23
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group22
Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis21
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications21
Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management21
Contribution of the microbiome for better phenotyping of people living with obesity21
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management21
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities21
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing20
Hypoprolactinemia. Does it matter? Redefining the hypopituitarism and return from a mumpsimus20
Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis20
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases20
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review20
Where are we in the diagnosis and treatment of hirsutism? A narrative review19
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies19
Incomplete penetrance and variable expressivity in monogenic diabetes; a challenge but also an opportunity19
Relevance of body composition in phenotyping the obesities19
The role of bioelectrical phase angle in patients with heart failure18
Redefining the timeline: a three-phase framework of hypothalamic microinflammation in metabolic disease18
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions17
Association of maternal blood metabolomics and gestational diabetes mellitus risk: a systematic review and meta-analysis17
Current practice in intermediate risk differentiated thyroid cancer – a review17
Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated st17
New insights in thyroid diagnosis and treatment16
Neuropsychological complications of hypoprolactinemia16
Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions16
Aging and androgens: Physiology and clinical implications16
Targeting the activin/myostatin - actrii pathway to preserve skeletal muscle mass in obesity: mechanistic insights and therapeutic perspectives15
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy15
Sexual dimorphism in the development and function of the melanocortin system15
Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy15
Obestatin: canonical and unexpected functions15
Reviews in endocrine and metabolic disorders14
Isolated hypoprolactinemia: The rarest of the rare?14
The effect of bariatric surgery on the expression of gastrointestinal taste receptors: A systematic review14
Endocrine-disrupting chemicals in cosmetics: mechanistic insights and their impact on human and skin health13
Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system13
Phase angle in assessment and monitoring treatment of individuals with respiratory disease13
Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist?13
Therapy for aggressive pituitary tumors and carcinomas13
Progress, challenges and perspectives in the management of hypopituitarism13
Metabolic-inflammatory memory: the common pathological basis and therapeutic targets of metabolic syndrome13
Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?13
Hypothalamic obesity13
Shared Brain factors in eating disorders and obesity: a systematic review of functional near-infrared spectroscopy (fNIRS) studies13
Hypothalamic actions of estrogens in the regulation of energy and glucose homeostasis13
Growth hormone – releasing hormone in the immune system12
Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage12
Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group12
Complexity in the interpretation and application of multiple guidelines for thyroid nodules: the need for coordinated recommendations for “small” lesions12
Phase angle, muscle tissue, and resistance training12
Pituitary adenomas: biology, nomenclature and clinical classification12
Hypothalamic control of puberty: from neuronal circuits to mechanisms for its metabolic regulation12
Primary hyperparathyroidism: from guidelines to outpatient clinic12
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism11
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review11
Emerging evidence and potential avenues to achieve durable outcomes in patients with obesity: the confluence of nutrition, and Microbiome on body composition11
Cognition and psychological wellbeing in hypopituitary patients11
Melatonin administration on bone properties of animals under hypoestrogenism: A systematic review11
Dynamic risk assessment in patients with differentiated thyroid cancer11
The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men11
Endocrinological and inflammatory markers in individuals with spinal cord injury: A systematic review and meta-analysis10
Natriuretic peptide receptor C in cardiovascular–kidney–liver–metabolic syndrome: from natriuretic peptide deficiency to direct tissue signaling?10
The use of phase angle in patients with digestive and liver diseases10
The evolving concept from Cardiovascular-kidney-metabolic syndrome to metabolic associated liver-cardiovascular-kidney syndrome: insights from endocrinology10
Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among U.S. individuals with low economic resources10
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care10
The changing landscape of acromegaly – an epidemiological perspective10
The science of bioelectrical impedance-derived phase angle: insights from body composition in youth10
Metabolic phenotyping in people living with obesity: Implications for dietary prevention10
Site-specific fracture risk in chronic hypoparathyroidism: systematic review and meta-analysis10
Thyroid cancer and insulin resistance9
Longitudinal dynamics of impulsivity in individuals undergoing obesity surgery – a systematic review9
Meal replacements on obesity and leptin: a systematic review and meta-analysis9
Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved9
The role of tissue oxygenation in obesity-related cardiometabolic complications9
The molecular basis of hypoprolactinaemia8
Role of HOXA10 in pathologies of the endometrium8
Advances in the application of artificial intelligence-driven multi-modal imaging technologies in the comprehensive diagnosis and treatment of diabetic foot ulcers8
The role of tanycytes in the regulation of energy balance8
Update on regulation of GHRH and its actions on GH secretion in health and disease8
GHRH and its analogues in central nervous system diseases8
The relationship between low prolactin and type 2 diabetes8
Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis8
A novel approach for the treatment of AML, through GHRH antagonism: MIA-6028
The medicalization of testosterone: reinventing the elixir of life8
Cardiometabolic effects of hypoprolactinemia8
Iron homeostasis and insulin sensitivity: unraveling the complex interactions8
The relationship between thyroid and human-associated microbiota: A systematic review of reviews8
Applying psycho-behavioural phenotyping in obesity characterization7
Childhood obesity: The threatening apprentice of the adiposity empire7
Targeting aging with the healthy skeletal system: The endocrine role of bone7
Diagnosis and management of secondary adrenal crisis7
Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia7
Hypothalamus-liver talks: whispers in the language of metabolism7
Bone as an endocrine regulator of lipid and energy metabolism7
Targeted therapeutic strategies as alternative and sustainable treatment options for obesity-induced steatohepatitis7
0.54010891914368